New partnership unlocks deeper HCP targeting, KOL mapping, and patient matching capabilities across global life sciences field teams
ACTO, an Intelligent Field Excellence (IFE) platform built for life sciences that improves field and HCP interactions with unified agentic AI, and Global Data Support (GDS), a global provider of strategic healthcare data intelligence, announce a partnership that empowers commercial and medical teams to better identify, target, and engage the right healthcare providers (HCPs) and expert centers—especially in rare disease and oncology.
By integrating GDS’s robust universe-based profiling and referral mapping into ACTO’s platform, field teams can now act faster, with greater precision, and improve performance across launches, targeting, and engagement strategies. The solution helps life sciences organizations go beyond traditional sampling methods to capture the full treatment landscape—driving sharper, data-driven interventions.
GDS’s offering allows organizations working with ACTO to find patients faster, map diagnosis pathways, and prioritize the HCPs and centers with the greatest strategic impact. This partnership also enables GDS to scale delivery of its solutions through ACTO’s field-focused ecosystem, helping organizations align and optimize teams, sharpen market execution, and improve field excellence with actionable insights.
Addressing Critical Human Challenges in Life Sciences
The life sciences sector requires precise, data-driven approaches to improve productivity and engagement. GDS is designed to:
- Identify the full universe of relevant HCPs, expert centers, and patient touchpoints—not just samples
- Accelerate patient finding and diagnosis path mapping in hard-to-reach therapeutic areas like rare diseases
- Provide real-world, actionable targeting models to boost field efficiency and commercial effectiveness
- Access the latest information on HCPs, KOLs, and other stakeholders, providing the ideal support for upcoming visits and meetings, including a summary of recent events, presentations, closest scientific connections, and upcoming events
- Tailor communication based on the HCPs scientific alignment with the product (likelihood to adopt)
A Unique Partnership Focused on Intelligent Field Deployment
The collaboration leverages GDS’s ability to deliver deep, localized HCP intelligence and referral network visibility paired with ACTO’s AI-powered platform for field readiness and execution. Together, the partnership eliminates guesswork in targeting and helps life sciences teams deploy with precision and impact.
“GDS’s universe-based approach and rare disease expertise, combined with ACTO’s Intelligent Field Excellence (IFE) platform, allow us to empower organizations to prioritize smarter, connect deeper, and ultimately reach more of the right patients faster,” said JoJo Kalita, ACTO’s Vice President of Partnerships and the ACTOverse. “This partnership represents a significant step forward in how we support launch excellence, targeting, and commercialization across global field teams.”
Key GDS Features
- Complete profiling of HCP and treatment center universe to provide more robust data than just sampling
- Rare disease- and oncology-targeting expertise in 25 countries and more than 300 disease areas
- Use of AI disease expertise correlation models to compensate for under diagnosed and misdiagnosed ICD10 claims
- Linking claims from US HCPs to their European connections to accelerate product adoption
- Bespoke targeting and segmentation data for individual clients, including access to the source files / raw data
- Real-world data mapping (ICD-10, trials, drug usage, procedures, etc.)
- Identification and tiering of target practices and clinicians outside of hospital settings
- Fully client-specific outputs: CRM-ready, Tableau, Excel, Microsoft BI
- GDPR- and CCPA-compliant with opt-in mechanisms
“Our mission is to help life sciences companies make faster, more informed decisions by providing a complete view of the patient journey and treatment landscape,” said Mark Kroes, Chief Executive Officer at Global Data Support. “We’re excited to work with ACTO to bring our strategic intelligence to more organizations and help drive real, measurable field performance across some of the most complex therapeutic areas.”
About ACTO
ACTO is an Intelligent Field Excellence (IFE) platform built for life sciences that unifies human intelligence with empathetic AI to help Sales, Medical, Market Access, and Marketing teams improve customer engagement and brand performance. With ACTO, biopharma companies can ensure field professionals are always competent, confident, and credible in face-to-face HCP interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness. As a validated platform compliant with FDA 21 CFR Part 11 and SOC 2 Type II certified, ACTO is the trusted partner for intelligent field excellence in the Life Sciences industry.
About Global Data Support (GDS)
Global Data Support (GDS) helps biopharma and pharmaceutical companies find patients, profile experts, and map treatment landscapes—especially in rare diseases and oncology. GDS specializes in turning unstructured data into strategic insights: identifying the right HCPs and centers of excellence, mapping diagnosis and referral pathways, and delivering real-world treatment data and expert networks. With a universe-based approach, deep local expertise in 25+ countries, and GDPR/CCPA-compliant tools, GDS empowers field teams and commercial leaders to deploy smarter and reach the right patients, faster. For more information, visit https://globaldatasupport.com.